Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report
Univ Kentucky, 311 Sanders Brown Ctr Aging, Lexington, KY 40536 USA.
Mayo Clin, Jacksonville, FL 32224 USA.ORCID iD: 0000-0001-7189-7917
Univ Penn, Philadelphia, PA 19104 USA.
Mayo Clin, Rochester, MN USA.
Show others and affiliations
2019 (English)In: Brain, ISSN 0006-8950, E-ISSN 1460-2156, Vol. 142, p. 1503-1527Article, review/survey (Refereed) Published
Abstract [en]

We describe a recently recognized disease entity, limbic-predominant age-related TDP-43 encephalopathy (LATE). LATE neuropathological change (LATE-NC) is defined by a stereotypical TDP-43 proteinopathy in older adults, with or without coexisting hippocampal sclerosis pathology. LATE-NC is a common TDP-43 proteinopathy, associated with an amnestic dementia syndrome that mimicked Alzheimer's-type dementia in retrospective autopsy studies. LATE is distinguished from frontotemporal lobar degeneration with TDP-43 pathology based on its epidemiology (LATE generally affects older subjects), and relatively restricted neuroanatomical distribution of TDP-43 proteinopathy. In community-based autopsy cohorts, similar to 25% of brains had sufficient burden of LATE-NC to be associated with discernible cognitive impairment. Many subjects with LATE-NC have comorbid brain pathologies, often including amyloid-beta plaques and tauopathy. Given that the oldest-old' are at greatest risk for LATE-NC, and subjects of advanced age constitute a rapidly growing demographic group in many countries, LATE has an expanding but under-recognized impact on public health. For these reasons, a working group was convened to develop diagnostic criteria for LATE, aiming both to stimulate research and to promote awareness of this pathway to dementia. We report consensus-based recommendations including guidelines for diagnosis and staging of LATE-NC. For routine autopsy workup of LATE-NC, an anatomically-based preliminary staging scheme is proposed with TDP-43 immunohistochemistry on tissue from three brain areas, reflecting a hierarchical pattern of brain involvement: amygdala, hippocampus, and middle frontal gyrus. LATE-NC appears to affect the medial temporal lobe structures preferentially, but other areas also are impacted. Neuroimaging studies demonstrated that subjects with LATE-NC also had atrophy in the medial temporal lobes, frontal cortex, and other brain regions. Genetic studies have thus far indicated five genes with risk alleles for LATE-NC: GRN, TMEM106B, ABCC9, KCNMB2, and APOE. The discovery of these genetic risk variants indicate that LATE shares pathogenetic mechanisms with both frontotemporal lobar degeneration and Alzheimer's disease, but also suggests disease-specific underlying mechanisms. Large gaps remain in our understanding of LATE. For advances in prevention, diagnosis, and treatment, there is an urgent need for research focused on LATE, including in vitro and animal models. An obstacle to clinical progress is lack of diagnostic tools, such as biofluid or neuroimaging biomarkers, for ante-mortem detection of LATE. Development of a disease biomarker would augment observational studies seeking to further define the risk factors, natural history, and clinical features of LATE, as well as eventual subject recruitment for targeted therapies in clinical trials.

Place, publisher, year, edition, pages
2019. Vol. 142, p. 1503-1527
Keywords [en]
PET, MRI, FTLD, epidemiology, SNAP
National Category
Neurology Neurosciences
Identifiers
URN: urn:nbn:se:uu:diva-393763DOI: 10.1093/brain/awz099ISI: 000481419700013PubMedID: 31039256OAI: oai:DiVA.org:uu-393763DiVA, id: diva2:1355230
Note

A correction has been published: Brain, Volume 142, Issue 7, July 2019, Page e37, https://doi.org/10.1093/brain/awz163

Available from: 2019-09-27 Created: 2019-09-27 Last updated: 2019-09-27Bibliographically approved

Open Access in DiVA

fulltext(1398 kB)10 downloads
File information
File name FULLTEXT01.pdfFile size 1398 kBChecksum SHA-512
786f6b65a15150f77cb835ff9e6901f0c0eed2aee6959b1218b4476a355e8e3ffdc671bb9fd7c3ce0dc6fd7aa01786728373f124f084b199bd6a364902b46be0
Type fulltextMimetype application/pdf

Other links

Publisher's full textPubMed

Search in DiVA

By author/editor
Dickson, Dennis W.Alafuzoff, IrinaBrayne, CarolKovacs, Gabor G.
By organisation
Clinical and experimental pathology
In the same journal
Brain
NeurologyNeurosciences

Search outside of DiVA

GoogleGoogle Scholar
Total: 10 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 26 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf